Buscar
17/11/2025
Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial
Lozano-Borbalas, A, Jordi-Ollero, O, Marruecos, J, Farre, N, Planas, I, Toledo, MD, Mesia, R, Navarro-Martin, A. Impact of clinical and dosimetric factors on severe oral mucositis in head and neck cancer: insights from a phase II clinical trial. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1679589. PMID:41333216. IF:3.300(Q2/4D).
01/01/2023
Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.
Czerwinska-Jelonkiewicz K, Wood A, Bohm A, Kwasiborski P, Oleksiak A, Ryczek R, Grand J, Tavazzi G, Sionis A, Stepinska J. Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest.. Cardiology Journal. 2023; 30(6)DOI:10.5603/CJ.a2021.0173. PMID:34967939. IF:2.500(Q2/5D).
21/11/2021
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
Zeymert, U, Ludman, P, Danchin, N, Kala, P, Laroche, C, Sadeghi, M, Caporale, R, Shaheen, SM, Legutko, J, Iakobsishvili, Z, Alhabib, KF, Motovska, Z, Studencan, M, Mimoso, J, Becker, D, Alexopoulos, D, Kereseselidze, Z, Stojkovic, S, Zelveian, P, Goda, A, Mirrakhimov, E, Bajraktari, G, Al-Farhan, H, Serpytis, P, Raungaard, B, Marandi, T, Moore, AM, Quinn, M, Karjalainen, PP, Tatu-Chitolu, G, Gale, CP, Maggioni, AP, Weidinger, F, Sionis A., ESC. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. EUROPEAN HEART JOURNAL. 2021; 42(44)DOI:10.1093/eurheartj/ehab342. PMID:34389857. IF:35.855(Q1/1D).
12/11/2021
Systematic Characterization of High-Power Short-Duration Ablation: Insight From an Advanced Virtual Model.
Petras A, Moreno Weidmann Z, Leoni M, Gerardo-Giorda L, Guerra JM. Systematic Characterization of High-Power Short-Duration Ablation: Insight From an Advanced Virtual Model.. Frontiers In Medical Technology. 2021; 3DOI:10.3389/fmedt.2021.747609. PMID:35047958. IF:(Q/D).
11/11/2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction
Pfeffer, MA, Claggett, B, Lewis, EF, Granger, CB, Kober, L, Maggioni, AP, Mann, DL, McMurray, JJV, Rouleau, JL, Solomon, SD, Steg, PG, Berwanger, O, Cikes, M, De Pasquale, CG, East, C, Fernandez, A, Jering, K, Landmesser, U, Mehran, R, Merkely, B, Mody, FV, Petrie, MC, Petrov, I, Schou, M, Senni, M, Sim, D, van der Meer, P, Lefkowitz, M, Zhou, Y, Gong, J, Braunwald, E, Sionis A., PARADISE-MI Invest & Comm. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. NEW ENGLAND JOURNAL OF MEDICINE. 2021; 385(20)DOI:10.1056/NEJMoa2104508. PMID:34758252. IF:176.082(Q1/1D).
02/09/2021
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Gerstein, HC, Sattar, N, Rosenstock, J, Ramasundarahettige, C, Pratley, R, Lopes, RD, Lam, CSP, Khurmi, NS, Heenan, L, Del Prato, S, Dyal, L, Branch, K, Sionis A., AMPLITUDE-O Trial Investigators. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE. 2021; 385(10)DOI:10.1056/NEJMoa2108269. PMID:34215025. IF:176.082(Q1/1D).